In patients with recurrent small hepatocellular carcinoma (HCC), stereotactic body radiotherapy (SBRT) demonstrated superior local progression-free survival (PFS) and tumor control at 3 years compared ...
AngioDynamics, Inc. announced expanded European indications for its NanoKnife system with irreversible electroporation (IRE) t ...
Microwave ablation (MWA) of colorectal liver metastases (CRLM) had low rates of failure and morbidity and warrants consideration as definitive treatment, authors of a large clinical review suggested.
Thermal ablation demonstrated noninferiority to surgical resection for small colorectal liver metastases, with comparable overall survival and local control outcomes. The COLLISION trial showed ...
A new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center may help explain why certain liver tumors return quickly after thermal ablation, a widely used ...
AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options ...
Surgery and radiofrequency ablation showed similar 5-year survival rates for small liver tumors. Both treatments had nearly identical 5-year recurrence-free survival outcomes. Patient and tumor ...
Resection of liver metastases is considered the only treatment with curative potential for patients with metastatic colorectal cancer to the liver (CRLM). However, only a minority of patients with ...
Hepatocellular carcinoma is the most common type of primary liver cancer. For most patients, treatment with curative intent is not possible. The treatment options include surgical excision, hepatic ...
An international randomized controlled trial, advised by a steering committee co-led by a senior clinician-scientist from the National Cancer Centre Singapore and Duke-NUS Medical School, Singapore, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results